BEIJING SCITOP BIO-TECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.59 CNY | -0.68% |
|
-14.02% | -24.40% |
| 2023 | Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| 2023 | Beijing Scitop Bio-tech Co., Ltd.(XSEC:300858) added to S&P Global BMI Index | CI |
| Sales 2023 * | 369M 50.94M | Sales 2024 * | 447M 61.71M | Capitalization | 3.84B 531M |
|---|---|---|---|---|---|
| Net income 2023 * | 112M 15.46M | Net income 2024 * | 139M 19.19M | EV / Sales 2023 * | 10.4 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 8.6 x |
| P/E ratio 2023 * |
33.9
x | P/E ratio 2024 * |
27.5
x | Employees | 263 |
| Yield 2023 * |
1.71% | Yield 2024 * |
1.92% | Free-Float | 42.98% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.68% | ||
| 1 week | -14.02% | ||
| Current month | -17.57% | ||
| 1 month | -20.49% | ||
| 3 months | -14.68% | ||
| 6 months | -18.99% | ||
| Current year | -24.40% |
1 week
13.81
15.96
1 month
13.8119.65
Current year
13.8119.88
1 year
13.8121.41
3 years
13.8132.99
5 years
11.5938.20
10 years
11.5938.20
| Managers | Title | Age | Since |
|---|---|---|---|
Xiao Jun Liu
CEO | Chief Executive Officer | 43 | - |
Zi Ying Yu
DFI | Director of Finance/CFO | 60 | - |
Tian Song Sun
CHM | Chairman | 56 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong Yue Liu
BRD | Director/Board Member | 61 | 16-12-15 |
Tian Song Sun
CHM | Chairman | 56 | - |
Xiao Jun Liu
CEO | Chief Executive Officer | 43 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 14.59 | -0.68% | 2 197 010 |
| 24-04-22 | 14.69 | +2.94% | 3,971,100 |
| 24-04-19 | 14.27 | -1.92% | 4,368,307 |
| 24-04-18 | 14.55 | -5.40% | 8,503,330 |
| 24-04-17 | 15.38 | 0.00% | 6,637,695 |
End-of-day quote Shenzhen S.E., April 22, 2024
More quotes
Beijing Scitop Bio-tech Co Ltd is a China-based company mainly engaged in the research, development, production and sales of compound food additives, edible probiotic products and animal and plant microecological preparations. The Company's main products include compound food additives, edible probiotic products, animal and plant microecological preparations and others. The Company mainly conducts its businesses within the China market.
Sector
Food Processing
Calendar
2024-04-24
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14.59
CNY
Average target price
17.67
CNY
Spread / Average Target
+21.11%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.40% | 534M | |
| +0.05% | 29.17B | |
| +12.43% | 11.81B | |
| +13.08% | 5.11B | |
| +9.21% | 4.23B | |
| -17.23% | 3.43B | |
| -2.12% | 3.17B | |
| -1.96% | 2.88B | |
| +25.46% | 2.8B | |
| +4.14% | 2.41B |
- Stock Market
- Equities
- 300858 Stock
